These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3725850)

  • 1. [Structure-release relationship of physical polymer/drug combinations. 2. Diffusion of 3-methylpyrazole through a synthetic polymer matrix].
    Schulz B; Bleyer C; Hartmann M
    Pharmazie; 1986 Feb; 41(2):118-20. PubMed ID: 3725850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure-release relationships of active polymeric drug combinations. 1. The influence of polymer structure on the diffusion of 3-methylpyrazole from monolithic systems].
    Schulz B; Pinther P; Hartmann M
    Pharmazie; 1985 Aug; 40(8):548-52. PubMed ID: 4080800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-release relationships of physically based polymer-biocide combinations. Part 3: Effect of the environment on the release of 3(5)-methylpyrazole from monolithic matrix systems.
    Schulz B; Hartmann M
    Pharmazie; 1988 Jan; 43(1):29-31. PubMed ID: 3375297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological properties and diffusion dissolution behaviour of hydrophilic polymers.
    Caramella C; Ferrari F; Bonferoni MC; Ronchi M; Colombo P
    Boll Chim Farm; 1989 Oct; 128(10):298-302. PubMed ID: 2635914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems.
    Kaunisto E; Marucci M; Borgquist P; Axelsson A
    Int J Pharm; 2011 Oct; 418(1):54-77. PubMed ID: 21256939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release from acrylic polymers via channels and cracks: in vitro studies with hydrocortisone.
    Brook IM; van Noort R
    Biomaterials; 1985 Jul; 6(4):281-5. PubMed ID: 4052543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different diffusion mechanism for drug molecules in amorphous polymers.
    Zhao ZJ; Wang Q; Zhang L; Liu YC
    J Phys Chem B; 2007 May; 111(17):4411-6. PubMed ID: 17428084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and in vitro assessment of sustained release terbutaline sulfate tablet made from binary hydrophilic polymer mixtures.
    Al-Akayleh F; Al Remawi M; Rashid I; Badwan A
    Pharm Dev Technol; 2013; 18(5):1204-12. PubMed ID: 21977992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
    Frank A; Rath SK; Venkatraman SS
    J Control Release; 2005 Feb; 102(2):333-44. PubMed ID: 15653155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Fickian and non-Fickian drug release from polymers.
    Peppas NA
    Pharm Acta Helv; 1985; 60(4):110-1. PubMed ID: 4011621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between the structure of polymers and the controlled release of active ingredients].
    Peppas NA; Gurny R
    Pharm Acta Helv; 1983; 58(1):2-8. PubMed ID: 6338530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis of drug weight preservation in a polymer container by the permeability coefficients].
    Artem'ev AI
    Farmatsiia; 1971; 20(1):77-82. PubMed ID: 5581149
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
    Ali J; Tyagi P; Ahuja A; Baboota S; Hasan S
    PDA J Pharm Sci Technol; 2007; 61(2):88-96. PubMed ID: 17479716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid/Hollow depots for drug delivery, part 1: effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release.
    Liu H; Venkatraman SS
    J Pharm Sci; 2014 Feb; 103(2):485-95. PubMed ID: 24357252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of histone H1 with pyran co-polymer.
    Reczek PR
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):105-14. PubMed ID: 7313294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.